Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC

Dr Karie Runcie - Columbia University, New York, USA
Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC ( Dr Karie Runcie - Columbia University, New York, USA )
17 Mar 2026

ASCO GU 2026: Updates in bladder cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in bladder cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

ASCO GU 2026: Updates in metastatic prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in metastatic prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

ASCO GU 2026: Updates in localised prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in localised prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

Tepotinib in second line NSCLC treatment

Dr Antonio Passaro and Prof Raffaele Califano
Tepotinib in second line NSCLC treatment ( Dr Antonio Passaro and Prof Raffaele Califano )
20 Jan 2026

Liquid biopsies as translational tools for advancing cancer immunotherapy in Africa

Dr Bodour Salhia - University of Southern California, Los Angeles, USA
Liquid biopsies as translational tools for advancing cancer immunotherapy in Africa ( Dr Bodour Salhia - University of Southern California, Los Angeles, USA )
19 Jan 2026

Current state of cancer genomics in Africa

Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia
Current state of cancer genomics in Africa ( Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia )
19 Jan 2026

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer

Dr Ricardo Pinto - i3S, Porto, Portugal
Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal
Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026

Integrating oncogenetics testing into African clinics and cancer control programs

Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria
Integrating oncogenetics testing into African clinics and cancer control programs ( Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria )
16 Jan 2026

African Oncogenetics Network: improving training and infrastructure in low-resource regions

Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda
African Oncogenetics Network: improving training and infrastructure in low-resource regions ( Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda )
15 Jan 2026

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA
Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )
15 Jan 2026